News

The deadlines for the following actions are March 19, 10 and 13, respectively. Please do this today, if possible. By Jeff Crater The Lyme community had a great success in December, when the Kay Hagan Tick Act was passed into law. But what can Lyme patients, friends, and relatives... Read More »

Dr. Steven Bock, a Lyme-treating physician, provides information about the coronavirus–and the risk it poses for people with Lyme disease. He explains about the immune system and ways that Lyme patients (and others with compromised immune systems) can protect themselves. Read More »

The federal Tick-Borne Disease Working Group held two days of meetings in Philadelphia on March 3 and 4. Panel members went through the recommendations of the eight subcommittees, accepting some and rejecting others. For the first time, the events were streamed via YouTube. Thus,... Read More »

The federal Tick-Borne Disease Working Group met in Philadelphia on March 3 and 4. Lonnie Marcum, of LymeDisease.org, live-tweeted the proceedings. Click here to read her tweets from Day One. Click below to read her tweets from Day Two. Read More »

The federal Tick-Borne Disease Working Group met in Philadelphia on March 3 and 4. LymeDisease.org’s Lonnie Marcum live-tweeted the proceedings. Click below to see her tweets for the first day. Click here to see tweets for the second day. Read More »

Journalist Mary Beth Pfeiffer has reported on Twitter that Anthem has become the fourth insurance company to settle in Torrey vs. IDSA et al. The lawsuit has been brought by a group of Lyme patients. They’re suing the Infectious Diseases Society of America, the authors of the... Read More »

The federal Tick-borne Disease Working Group will convene March 3 and 4, in Philadelphia, PA. The meeting will be held at the College of Physicians of Philadelphia, 19 S. 22nd Street. On both days, the meetings begin at 9 am ET. The agenda calls for panelists to discuss and vote... Read More »

The Spring 2020 issue of the Lyme Times features four articles about disulfiram. The drug has been around for 70 years, but has only recently been used for Lyme disease. Many patients and their doctors report success–but also urge caution. Other topics covered in this... Read More »

According to a new study, the CDC’s standard two-tier testing for Lyme disease failed to accurately diagnose more than 70% of blood samples from individuals with an erythema migrans rash greater than 5 centimeters across. Additional findings showed that Lyme disease also occurred... Read More »